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Work has shown that stem cell transplantation can rescue or replace neurons in models of retinal degenerative disease. Neural
progenitor cells (NPCs) modiﬁed to overexpress neurotrophic factors are one means of providing sustained delivery of therapeutic
gene products in vivo. To develop a nonrodent animal model of this therapeutic strategy, we previously derived NPCs from the
fetal cat brain (cNPCs). Here we use bicistronic feline lentiviral vectors to transduce cNPCs with glial cell-derived neurotrophic
factor (GDNF) together with a GFP reporter gene. Transduction eﬃcacy is assessed, together with transgene expression level
and stability during induction of cellular diﬀerentiation, together with the inﬂuence of GDNF transduction on growth and gene
expression proﬁle. We show that GDNF overexpressing cNPCs expand in vitro, coexpress GFP, and secrete high levels of GDNF
protein—before and after diﬀerentiation—all qualities advantageous for use as a cell-based approach in feline models of neural
degenerative disease.
1.Introduction
The retina is susceptible to a variety of degenerative diseases,
including age-related macular degeneration (AMD), retinitis
pigmentosa (RP) and other inherited photoreceptor degen-
erations, photoreceptor loss following retinal detachment,
ganglioncelllossinglaucomaandopticneuropathies,aswell
asthelossofretinalneuronsassociatedwithnondegenerative
conditions such as diabetic retinopathy (DR), macular
edema and ischemia, vascular occlusions, trauma, and
inﬂammatory diseases. Any of these can lead to debilitating
visualdeﬁcits.AMDisaparticularlyprevalentcauseofblind-
ness among elderly persons, aﬀecting more than 30 million
people globally. That number is expected to double over the
next decade in association with demographic shifts towards
an older population, particularly in developed countries [1].
Similartothesituationwithmanyneurologicaldiseases,little
isavailableinthewayofeﬀectivetreatmentsforpatientswith
AMD or other blinding disorders of the retina.
A large body of research has shown that the use of
exogenous neurotrophic factors can reproducibly promote
the survival of speciﬁc neurons in various parts of the
central nervous system (CNS), including the retina [2, 3].
Frequentlyinvestigatedneuroprotectiveneurotrophicfactors
have included glial cell line-derived neurotrophic factor
(GDNF), brain-derived neurotrophic factor (BDNF), and
ciliary neurotrophic factor (CNTF). Among these, GDNF
has been associated with signiﬁcant eﬀects with respect to
preventing cell death [4], including the protection of speciﬁc
neuronal populations in the brain [5, 6], spinal cord [7],2 Journal of Ophthalmology
and retina [8–11]. Receptors for GDNF are known to be
expressed within the mature retina [8, 11, 12].
Stem and progenitor cell transplantation has also shown
considerable promise in animal models of neural degener-
ation. Subretinal transplantation of neural progenitor cells
(NPCs) has yielded intriguing evidence of cellular repopu-
lation of damaged retinas, growth of neurites into the optic
nerve head and retardation of ongoing retinal degeneration
[13–17]. Both unmodiﬁed, as well as genetically modiﬁed,
cortical human NPCs can survive for prolonged periods,
migrate extensively, secrete growth factors, and rescue visual
function following subretinal transplantation in the dys-
t r o p h i cR o y a lC o l l e g eo fS u r g e o n sr a t[ 18], with sustained
visual beneﬁts following injection [19]. More recently, sub-
retinal transplantation of human forebrain progenitor cells
hasbeenextendedtononhumanprimates[20],althoughthis
model used nondystrophic hosts and therefore did not lend
itselftoevaluationofneuroprotectiveeﬃcacy.Whenusedfor
transplantation therapy, NPCs engineered to secrete GDNF
contributed to reduced apoptotic death in vitro, enhanced
survival in vivo, neuronal diﬀerentiation, and improved
host cognitive function following traumatic brain injury as
compared with nontransduced NPCs [21–24].
The visual system of the cat is quite sophisticated and
one of the most extensively studied among higher mammals.
There are many similarities to the human retina although
that of the cat has a tapetum and is generally optimized for
performance under scotopic conditions [25]. Like humans,
the cat is a species with a robust intraretinal circulation
[26]. The cat retina has also been the subject of decades of
anatomical and physiological studies and has been used as an
animal model of binocular visual function as well as studies
involving drug treatment and research on retina detachment
[27, 28]. In addition, the feline eye is large relative to
that of rodents thereby allowing the application of surgical
techniques similar to those typically used clinically. Finally,
there exist feline models of retinal degeneration caused by
spontaneous mutations in genes known to be involved in
retinitis pigmentosa in humans [29, 30]. These animals
provide excellent models for exploring the therapeutic
potential of stem cell-based neuroprotective strategies in an
animal with highly developed visual capabilities.
Previously, we showed that it is possible to derive NPCs
from the developing cat brain and that these cells are capable
of integration into the retina of dystrophic feline recipients
[23]. To more fully exploit the potential of this model, it is
useful to develop feline NPCs capable of sustained growth
factor delivery to the host retina. Here we use a bicistronic
feline lentiviral vector to generate genetically modiﬁed feline
neural progenitor cells that exhibit sustained overexpression
of GDNF before and after diﬀerentiation.
2.MaterialsandMethods
2.1. Isolation and Culture of Neural Progenitor Cells from
Feline Brain. Cat neural progenitor cells (cNPCs) were orig-
inally isolated from 47 day cat fetuses as previously described
[23].Brieﬂy,forebrainswereremovedandﬁnelymincedwith
a surgical scalpel and the resulting tissue fragments digested
for 20 minutes in 0.1% type I collagenase (Invitrogen, Carls-
bad, CA). The supernatant containing dissociated cells was
then passed through a 100mm mesh strainer, centrifuged,
and seeded in complete culture medium, designated here as
standardmedium(SM),consistingofadvancedDMEM/F12,
1% N2 neural supplement, 2mM L-glutamine, 50mg/mL
penicillin-streptomycin, and epidermal and basic ﬁbroblast
growth factors (recombinant human EGF and bFGF, Invit-
rogen), both at ﬁnal concentrations of 20ng/mL. After initial
isolation, all medium was changed to an Ultraculture-based
composition,identicaltotheabovebutinwhichDMEM/F12
was replaced with Ultraculture serum-free medium (Lonza,
Basel, Switzerland). Therefore, in the present study standard
proliferation medium was Ultraculture-based with growth
factors and is designated (UM), whereas diﬀerentiation
medium was Ultraculture-based as well, but did not contain
addedgrowthfactorsanddidinclude10%fetalbovineserum
(UM-FBS). Culture medium was changed every 2 days and
proliferating cells passaged at regular intervals of 4-5 days.
2.2. Lentivector Production and Titer Determination. The
lentiviral vector used in this study was an FIV-based
bicistronic vector (GeneCopoeia, Germantown, Mary-
land) designated as lenti-GDNF-GFP, which carries a
human GDNF gene driven by the cytomegalovirus (CMV)
immediate-early promoter as well as an enhanced green
ﬂuorescent protein (GFP) reporter gene with an internal
ribosome entry site (IRES). Lenti-GDNF-GFP vectors were
prepared by transient transfection of 293T cells using a stan-
dard calcium phosphate precipitation protocol (Clontech,
Mountain View, CA). Brieﬂy, 293T cells cultured in 10cm
tissue culture dishes (BD Biosciences, San Jose, CA) were
transfected with 2μg of lentiviral transfer vector plasmid,
along with 10μg of the mixed envelope and packaging
plasmids. The viral supernatants were harvested 48 and 72
hours posttransfection and concentrated by centrifugation
ofvirus-containingsupernatantthroughaCentriconPlus-70
ﬁlter (Millipore, Billerica, MA) following the manufacturer’s
instruction. Titers of the concentrated lentivector were esti-
mated by transducing cNPC cells with a serial dilution of the
virusandﬂowcytometricidentiﬁcationofGFP-positivecells.
2.3. Lentiviral Vector Transduction. Cat neural progenitor
cells were transduced with lenti-GDNF-GFP vectors at a
MOI of 10 following the standard procedure. Brieﬂy, cNPCs
were seeded at a density that allowed them to grow to 90%
conﬂuency on the day of transduction. The cells were then
transduced by 6−24 hours of exposure to virus-containing
supernatant in the presence of 5−8μg/mL polybrene. Viral
vector-containing medium was then replaced with fresh
mediumandcellswereincubatedat37◦CinaCO 2 incubator.
2.4. FACS Analysis and Selection of Lenti-GDNF-GFP Positive
cNPCs. Cells were harvested using TrypLE Express (Invitro-
gen) and ﬁltered through cell strainer caps (35μm mesh)
to obtain a single cell suspension (approximately 106 cells
per mL for analysis, 0.5−2 × 107 cells per mL for sorting).Journal of Ophthalmology 3
The stained cells were analyzed and sorted on a ﬂuorescence-
activated cell sorter FACSAria (BD Biosciences) using FACS-
Diva software (BD Biosciences). The ﬂuorochromes were
excited by the instrument’s standard 488nm and 633nm
lasers, and green ﬂuorescence was detected using 490 LP and
510/20ﬁlters.Priortosorting,thenozzle,sheath,andsample
lines were sterilized with 70% ethanol or 2% hydrogen
peroxide for 15 minutes, followed by washes with sterile
water. A 100μm ceramic nozzle (BD Biosciences), sheath
pressure of 20−25 pounds per square inch (PSI), and an
acquisition rate of 1,000−3,000 events per second were used
as conditions previously optimized for neuronal cell sorting.
2.5. Cell Growth Assessment. The growth properties of
transduced and nontransduced cNPCs were assessed by
culturingbothtypesofcellsunderproliferationconditionsin
Ultraculture-based medium (UM). Cells of identical passage
number (p17) were seeded in four T25 culture ﬂasks at a
density of 0.25 million cells/ﬂask. One ﬂask of each cell
type were trypsinized and counted daily. Cell numbers were
graphedateachtime point tocomparethe growthproperties
of transduced versus nontransduced cells.
2.6. ELISA Analysis. Transduced and nontransduced cNPCs
ofidenticalpassagenumberwereseededinT25cultureﬂasks
(0.25million/ﬂask). Following attachment of cells (approx.
4 hours), the original media were replaced with 3mL
of fresh media. Subsequently, 3mL of conditioned media
were collected and replaced with fresh media at 24 hour
intervals and conditioned samples were saved at −80◦Cf o r
ELISA analysis. ELISA was performed using a human GDNF
DuoSet ELISA kit and protocol (R&D Systems, Minneapolis,
MN).W ellsofmicrotiterplateswerecoated(overnight,room
temperature) with 2μg/mL of GDNF capture antibody in
100μL of coating buﬀer (0.05M Na2CO3, 0.05 M NaHCO3,
pH 9.6) and then blocked with 0.1% BSA in PBS for 1
hour at room temperature. Samples (100μL) were loaded in
triplicates and incubated for 2 hours at room temperature,
followed by addition of 100μL antibody detection antibody
(0.1μg/mL) for an additional 2 hours at room temperature.
HRP-conjugated streptavidin (1:200) in blocking buﬀer
was then added (20 minutes, room temperature) and the
reaction visualized by the addition of 100μLo fs u b s t r a t e
solution for 20 minutes. The reaction was stopped with
50μLH 2SO4 and absorbance at 450nm was measured
with reduction at 540nm using an ELISA plate reader.
Plates were washed ﬁve times with washing buﬀer (PBS,
pH 7.4, containing 0.05% (v/v) Tween 20) after each step.
As a reference for quantiﬁcation, a standard curve was
establishedbyaserialdilutionofrecombinantGDNFprotein
(31.25pg/mL−2.0ng/mL).
2.7. Reverse Transcription and Quantitative PCR (qPCR)
Analysis. Total RNA was extracted from each sample using
the RNeasy Mini Kit (Qiagen, Valencia, CA). DNaseI
was used to eliminate the possibility of genomic DNA
contamination. RNA concentration was measured at
a wavelength of 260nm (A260) for each sample, and
the purity of isolated total RNA was determined by the
A260/A280 ratio. Quantitative RT-PCR analyses were only
performed on samples with A260/A280 ratios between 1.9
and 2.1. Two micrograms of total RNA in a 20μLr e a c t i o n
were used for reverse transcription using an Omniscript
cDNA Synthesis Kit (Qiagen, Valencia, CA). A primer set
for each gene (Table 1) was designed using the cat genome
browser (http://lgd.abcc.ncifcrf.gov/cgi-bin/gbrowse/cat/)
and the primers synthesized commercially (Invitrogen).
Quantitative PCR was performed using an Applied
Biosystems 7500 Fast Real-Time PCR Detection System
(Applied Biosystems, Foster, CA). Triplicate wells were used
f o re a c hg e n e .At o t a lv o l u m eo f2 0μL per well containing
10μL of 2x Power SYBR Green PCR Master Mix (Applied
Biosystems, Foster, CA), 2μL of cDNA and gene-speciﬁc
primers were used. Cycling parameters for qPCR were
as following: the initial denaturation was at 95◦Cf o r1 0
minutes, followed by 40 cycles of 15s at 95◦C and 1 minute
at 60◦C. To normalize template input, β-actin was used
as an endogenous control and transcript level measured
for each plate. The relative expression of the gene of
interest was then evaluated using 7500 Fast System Sequence
Detection Software, Version 1.4. The value obtained for Ct
represents the number of PCR cycles at which an increase
in ﬂuorescence signal (and therefore cDNA) can be detected
above background and the increase is exponential for the
particular gene. Data were expressed as fold change relative
to untreated controls after normalizing to β-actin. Error bars
displayed the calculated maximum and minimum standard
errors to the mean expression level of the triplicates.
2.8. Diﬀerentiation of Transduced cNPCs In Vitro. Trans-
duced cNPCs were diﬀerentiated in UM without added EGF
or bFGF and containing 10% FBS (UM-FBS). Cells (0.2
million)inUMwereseededinT25cultureﬂasksandallowed
to attach, then culture medium was aspirated and replaced
with either UM-FBS for diﬀerentiation or fresh UM for
comparison. Conditioned media were collected and replaced
with fresh media every 24 hours for 4 days and frozen for
ELISA analysis. At the end of day 4, cells were trypsinized,
counted, and ELISA analysis was performed on lysates as
wellasthawedmediasamples.ForFACSanalysis,transduced
c N P C sw e r ec u l t u r e di ne i t h e rU M - F B So rU Mf o r1 0d a y s
prior to processing.
2.9. Immunocytochemistry. Transduced and nontransduced
c N P C sw e r es e e d e di n4 - w e l lc h a m b e rs l i d e s( N a l g eN u n c
International, Rochester, NY) and allowed to grow for
3−5d a y s .C e l l sw e r er e - f e de v e r y2d a y sa n dﬁ x e dw i t h
freshly prepared 4% paraformaldehyde (Invitrogen) in 0.1M
phosphate-buﬀered saline (PBS) for 20 minutes at room
temperatureandwashedwithPBS.Cellswerethenincubated
in antibody blocking buﬀer consisting of PBS containing
10% (v/v) normal goat serum (NGS) (Biosource, Camarillo,
CA), 0.3% Triton X-100, 0.1% NaN3 (Sigma-Aldrich, Saint
Louis, MO) for 1 hour at room temperature. Slides were
incubated in primary antibodies (Table 2) overnight at 4◦C.
After washing the next morning, slides were incubated in4 Journal of Ophthalmology
Table 1: Cat-speciﬁc primers for quantitative RT-PCR (GDNF = human).
Gene Forward primer (5 -3 ) Reverse primer (5 -3 )
β-actin GCCGTCTTCCCTTCCATC CTTCTCCATGTCGTCCCAGT
Nestin CTGGAGCAGGAGAAGGAGAG GAAGCTGAGGGAAGCCTTG
Sox2 ACCAGCTCGCAGACCTACAT TGGAGTGGGAGGAAGAGGTA
Vimentin ATCCAGGAGCTACAGGCTCA GGACCTGTCTCCGGTACTCA
Pax6 AGGAGGGGGAGAGAATACCA CTTTCTCGGGCAAACACATC
Hes1 GCCAGCAGATATAATGGGAGA GCATCCAAAATCAGTGTTTTCA
Hes5 CTCAGCCCCAAAGAGAAGAA AGGTAGCTGACGGCCATCTC
Notch1 CAGTGTCTGCAGGGCTACAC CTCGCACAGAAACTCGTTGA
Mash1 CATCTCCCCCAACTACTCCA CCAACATCGCTGACAAGAAA
Ki-67 TCGTCTGAAGCCGGAGTTAT TCTTCTTTTCCCGATGGTTG
DCX GGCTGACCTGACTCGATCTC GCTTTCATATTGGCGGATGT
β3-tubulin CATTCTCGTGGACCTTGAGC GCAGTCGCAATTCTCACATT
Map2 ACCTAAGCCATGTGACATCCA CTCCAGGTACATGGTGAGCA
PKC-alpha TTCACAAGAGGTGCCATGAA CCATACAGCAATGACCCACA
GFAP CGGTTTTTGAGGAAGATCCA TTGGACCGATACCACTCCTC
Lhx2 GATCTGGCGGCCTACAAC AGGACCCGTTTGGTGAGG
CD81 CCACAGACCACCAACCTTCT CAGGCACTGGGACTCCTG
CD133 AGGAAGTGCTTTGCGGTCT TGCCAGTTTCCGAGTCTTTT
NCAM (CD56) AGAACAAGGCTGGAGAGCAG TTTCGGGTAGAAGTCCTCCA
EGFR AACTGTGAGGTGGTCCTTGG CGCAGTCCGGTTTTATTTGT
NagoA TTTGCAGTGTTGATGTGGGTA TAACAGGAACGCTGAAGAGTGA
SDF1 ACAGATGTCCTTGCCGATTC CCACTTCAATTTCGGGTCAA
CXCR4 TCTGTGGCAGACCTCCTCTT TTTCAGCCAACAGCTTCCTT
Cyclin D2 CAAGATCACCAACACGGATG ATATCCCGCACGTCTGTAGG
Pbx1 CTCCGATTACAGAGCCAAGC GCTGACCATACGCTCGATCT
FABP7 TGGAGGCTTTCTGTGCTACC TGCTTTGTGTCCTGATCACC
AQP4 TACACTGGTGCCAGCATGA CACCAGCGAGGACAGCTC
Nucleostemin CAGTGGTGTTCAGAGCCTCA CCGAATGGCTTTGCTGTAA
Synapsin1 ACGACGTACCCTGTGGTTGT CGTCATATTTGGCGTCAATG
Caspase 3 ATGGAGAACAGTGAAAACTCAGTGG AATTATTATACATAAACCCATTTCAGG
Bax 4 CTGAGCAGATCATGAAGACAGG GTCCAGTTCATCTCCGATGC
hGDNF∗ TGGGCTATGAAACCAAGGAG CAACATGCCTGCCCTACTTT
∗Human GDNF gene.
ﬂuorescent-conjugated secondary antibody (Alexa Fluor546
goat anti-mouse or goat anti-rabbit, 1:800 in PBS, BD)
for 1 hour at room temperature. After washing, DAPI-
containing Vectashield Hard Set Mounting Medium (Vector
Laboratories, Burlingame, CA) was used to mount the slides
for 20 minutes at room temperature. Negative controls
for immunolabeling were performed in parallel using the
same protocol but without primary antibody. Fluorescent
staining was judged as positive only with reference to the
negative controls. Immunoreactive cells were visualized and
imaged using a ﬂuorescent microscope (Eclipse E600, Nikon,
Melville, NY).
3. Results
3.1. Transduction of Proliferating cNPCs by FIV-Based Vector.
Currently, there are relatively few molecular tools with
enhanced speciﬁcity for feline cells. Recent development of
feline immunodeﬁciency virus- (FIV-) based vectors could
presentameansforimproveddeliveryoftransgenesintocells
of this species. Here, we employed an FIV-based bicistronic
vector for delivery of glial cell line-derived neurotrophic
factor (GDNF) to cat neural progenitor cells (cNPCs).
Forty eight hours after lenti-GDNF-GFP viral vector trans-
duction, approximately 50% of cNPCs expressed the GFP
reporter gene based on direct observation via ﬂuorescence
microscopy. To enrich for transgene-expressing cells, cNPCs
were trypsinized at 72 hours postviral vector incubation and
sorted by FACS based on GFP expression. The GFP-enriched
population was subsequently cultured in Ultraculture-based
proliferation medium (UM) for more than 60 days. High
levels of GFP expression were sustained throughout this time
period (Figure 1).
3.2. Expression of the GDNF Transgene Did Not Abrogate
cNPC Proliferation. GDNF is known to have a range ofJournal of Ophthalmology 5
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Figure 1: GDNF-transduced cNPCs: morphology and reporter gene expression. Feline NPCs transduced using a bicistronic lenti-GDNF-
GFP vector and cultured under proliferation conditions (UM) for 60 days (p9−p26). Cellular growth, morphology, and GFP expression
were monitored over this time period. In this ﬁgure, paired phase contrast ((a), (c), (e), (g), (i), (k)) and ﬂuorescence ((b), (d), (f), (h), (j),
(l)) micrographs of the same ﬁeld are presented for each of 6 sequential time points, as indicated. Transduced cNPCs exhibited consistent
mophologies, continued growth, and sustained GFP expression throughout the period examined. Bars = 100μm.
Table 2: Primary antibodies used for immunocytochemistry on cNPCs.
Target Antibody type Reactivity in retina Source Dilution
Nestin Mouse monoclonal Progenitors, reactive glia BD 1:200
Vimentin Mouse monoclonal Progenitors, reactive glia Sigma 1:200
Ki-67 Mouse monoclonal Proliferating cells BD 1:200
GFAP Mouse monoclonal Astrocytes, reactive glia Chemicon 1:200
β3-tubulin Mouse monoclonal Immature neurons Chemicon 1:200
GDNF Rabbit polyclonal Growth factor SCBT 1:2006 Journal of Ophthalmology
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Figure 2: Growth properties of transduced versus nontransduced
cNPCs. The growth of lenti-GDNF-GFP vector transduced cNPCs
was compared to nontransduced cNPCs under proliferation con-
ditions (UM). One ﬂask of each type of cells was harvested and
counted daily for 3 consecutive days. From this data it can be
seen that the transduced cNPCs continued to proliferate despite
overexpression of GDNF and that growth was similar to that of
nontransduced cells out to day 2, after which the nontransduced
cells exhibited relatively greater growth at the day 3 time point.
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Figure 3: Flow cytometric analysis of GFP expression after
induction of diﬀerentiation. Nontransduced cNPCs and lenti-
GDNF-GFP vector transduced cNPCs cultured under proliferation
conditions (UM) were compared to transduced cNPCs cultured
for 10 days in Ultraculture-based medium without EGF or bFGF
and containing 10% FBS in order to induce diﬀerentiation (UM-
FBS). Curve A: nontransduced cNPCs as negative controls; curve B:
lenti-GDNF-GFPtransducedcNPCsandcurveC:lenti-GDNF-GFP
transduced cNPCs in UM-FBS. Induction of diﬀerentiation did not
attenuate expression of the GFP reporter gene.
biological activities in the context of the nervous system
and cultured neural cell populations. Because this activity
might extend to neural progenitors, we examined the eﬀect
of GDNF transduction on cNPC behavior, speciﬁcally the
ability to proliferate. Proliferation is an important consid-
eration for large-scale expansion of modiﬁed donor cell
populations for use in transplantation studies. Transduced
cNPCs continued to proliferate in a logarithmic manner,
similar to but slightly slower than the nontransduced cNPCs
(Figure 2). Conversely, the transduced cNPCs appeared to
be somewhat more uniform, with less clumping and fewer
ﬂoating cells, particularly when cells were cultured for more
than 3 days in the same ﬂask.
3.3. Transgene Expression Was Maintained under Diﬀerenti-
ation Conditions. Neuronal diﬀerentiation has been impli-
cated in gene silencing; therefore FACS analysis was per-
formedtoevaluatetheeﬀectsofcelldiﬀerentiationonGDNF
transgene expression using the GFP reporter. Approximately
95% of transduced cNPCs expressed GFP, either when
cultured in UM (proliferation conditions) or 10% FBS-
containing UM (diﬀerentiation conditions). Among the
cells expressing GFP, approximately 70% expressed GFP
at high levels. There was no evidence of diminished GFP
expression by the cells grown in the presence of FBS, thereby
demonstrating maintained transgene expression was under
diﬀerentiation conditions (Figure 3).
3.4. Transduced cNPCs Produced and Secreted Elevated Levels
of GDNF. The levels of GDNF produced by transduced
cNPCs, as present in conditioned culture medium and
collected cell lysates, were analyzed by ELISA and com-
pared to nontransduced controls. High levels of secreted
GDNF were present in the culture medium of transduced
cNPCs, measured on days 28, 33, and 38 posttransduction
(Figure 4(a)). In addition, GDNF expression levels were con-
siderably elevated in cell lysates extracted from transduced
cultures on days 33 and 38 post-transduction (Figure 4(b)).
Hence, transduced cNPCs continued to produce elevated
levels of GDNF over a sustained period of time.
3.5. GDNF Expression Was Maintained under Diﬀerentia-
tion Conditions. Having shown above that expression of
the GFP reporter was sustained when transduced cNPCs
were subjected to diﬀerentiation conditions, and that the
transduced cells overexpress GDNF, we next veriﬁed that
GDNFexpressionwassustainedduringcNPCdiﬀerentiation
(Figure 5). Transduced cNPCs were cultured in UM without
added growth factors and containing 10% FBS to induce cell
diﬀerentiation and media were collected for ELISA. The level
of GDNF produced under diﬀerentiation conditions was not
diminished relative to proliferation conditions.
3.6. Eﬀect of GDNF Overexpression on Neural Diﬀerentiation.
Neural progenitor cells have shown great promise as a
source of neural cell types in transplantation studies. We
therefore investigated whether genetically modiﬁed cNPCs
retained their neural progenitor phenotype in the presence
of high levels of GDNF expression, as assessed by a gene
expression proﬁle (Figure 6). qPCR analysis showed that
transduced cNPC cells exhibited approximately 14,000-fold
GDNF upregulation at the mRNA level compared to non-
transduced controls. In transduced cells, expression levels of
the progenitor cell markers nestin, vimentin, and sox2, as
well as the neuronal marker β3-tubulin and the proliferation
markerKi-67remainedsimilartothatseeninnontransducedJournal of Ophthalmology 7
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Figure 4: ELISA analysis of GDNF production by transduced cNPCs. (a) Lenti-GDNF-GFP vector transduced and nontransduced cells at
passage 17 (cNPCp17) were seeded equally, under identical conditions, and allowed to grow for 15 days in UM, over which period the cells
were passaged 3 times. At the time of each passage, culture media conditioned over the prior 48 hours was collected for ELISA assay. The
conditioned media from transduced cNPCs was substantially enriched for GDNF compared to nontransduced cells. (b) Lenti-GDNF-GFP
transduced and nontransduced cNPCp17 cells were trypsinized, lysed, and subjected to ELISA. GDNF was markedly elevated in lysates of
transduced cells.
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Figure 5: Eﬀect of cell diﬀerentiation on transgene GDNF expres-
sion by ELISA. Lenti-GDNF-GFP vector transduced cNPCp24
cells were seeded equally in either UM (proliferation conditions)
or Ultraculture-based medium without additional growth factors
but containing 10% FBS (diﬀerentiation conditions, UM-FBS).
Cultures were fed 24 hours prior to collecting GDNF conditioned
media for ELISA assay at which time the cells were counted. ELISA
data is presented as GDNF (ng) per million cells per day in order to
further evaluate whether diﬀerentiation of transduced cNPCs had
aninﬂuenceontransgeneexpression.Thesedataareconsistentwith
sustained GDNF overexpression, conﬁrming the ﬂow cytometric
data (Figure 3) that showed no evidence of diminished reporter
gene expression in the UM-FBS treated population of transduced
cNPCs.
cells. Transduced cells also exhibited increased transcript
levels for stromal cell-derived factor-1 (SDF1, 4.2-fold),
prominin (CD133, 2.9-fold), doublecortin (DCX, 2.4-fold),
and Hes1 (1.45-fold), as well as lower transcript levels for
CXCR4, FABP7 and NCAM.
3.7. Examination of Protein Expression Using Immunocyto-
chemistry. Immunocytochemical analysis demonstrated that
cNPCs produced low levels of GDNF protein at baseline
(Figure 7(a)), but that expression of the protein was sub-
stantially elevated following transduction with Lenti-GDNF-
GFP (Figure 7(b)). To investigate the eﬀect of diﬀerentiation
on GDNF protein overexpression, cNPCs were cultured in
either serum-freeUM or UMcontaining 10% FBS for 5 days.
Following the induction of diﬀerentiation, the cells appeared
larger in size and GDNF expression was sustained, although
heterogeneity of expression levels across the population was
evident (Figure 7(c)).
The expression of progenitor and lineage markers was
also examined at the protein level, for both transduced and
control cells, before and after induction of diﬀerentiation
(Figure 8). The results veriﬁed the diﬀerentiating inﬂuence
of the FBS-containing condition as follows. The neural
progenitor cell marker nestin was only detected in cells
grown in UM and was not seen in UM-FBS. Likewise,
vimentin expression also decreased upon diﬀerentiation,
although for this less-speciﬁc marker expression remained
substantial. In contrast, β-tubulin III immunoreactivity was
strikingly up-regulated in a subset of cells grown in UM-
FBS, suggesting the induction of neuronal lineage. The
proliferation marker Ki-67 was clearly downregulated in8 Journal of Ophthalmology
0
.
3
7
6
1
.
2
8
8
0
.
6
1
1
.
2
1
5
2
.
9
3
6
1
.
0
6
9
0
.
0
9
1
.
0
0
8
2
.
4
3
1
0
.
6
7
5
0
.
1
7
5
1
.
4
3
2
e
 
+
 
0
0
4
0
.
6
4
9
0
.
7
4
5
0
.
2
2
4
0
.
8
8
1
.
4
2
0
.
6
1
6
0
.
0
9
9
0
.
9
8
3
0
.
4
6
9
0
.
9
2
6
0
.
7
2
6
0
.
3
9
8
1
.
4
5
2
1
.
0
5
0
.
6
8
8
4
.
1
7
0
.
1
9
7
0
.
6
2
5
0
.
4
7
4
0
1
2
3
4
5
1450
F
o
l
d
c
h
a
n
g
e
A
Q
P
4
B
3
-
t
u
b
u
l
i
n
B
a
x
4
C
a
s
p
a
s
e
3
C
D
1
3
3
C
D
8
1
C
X
C
R
4
C
y
c
l
i
n
D
2
D
c
x
E
F
G
R
F
A
B
P
7
G
D
N
F
G
F
A
P
H
e
s
1
H
e
s
5
K
i
-
6
7
L
h
x
2
M
a
p
2
M
a
s
h
1
N
C
A
M
(
C
D
5
6
)
N
e
s
t
i
n
n
o
g
o
A
N
o
t
c
h
1
N
u
c
l
e
o
s
t
e
m
i
n
P
a
x
6
P
b
x
1
P
K
C
-
a
l
p
h
a
S
D
F
1
S
o
x
2
S
y
n
a
p
s
i
n
1
V
i
m
e
n
t
i
n
Figure 6: Expression proﬁles of cNPCs before and after transduction. The relative impact of GDNF overexpression on transcript expression
levels was evaluated using qPCR analyses for a proﬁle of 32 genes, which included β-actin as a housekeeping gene. Lenti-GDNF-GFP vector
transduced cNPCp20 cells were compared to nontransduced cNPCp20 cells (with nontransduced cells set to 1.00). GDNF transcript level
was over 14,000-fold higher in transduced versus nontransduced cells (note that Y-axis has break to accommodate value). The value for
GDNF was vastly greater than any other changes in transcript level across the proﬁle examined.
(a) (b)
50μm
(c)
Figure 7: GDNF expression by cNPCs before and after transduction and diﬀerentiation. Immunocytochemistry (ICC) was performed on
cNPCs using a rabbit anti-human GDNF antibody to evaluate expression of GDNF at the protein level, before and after transduction and
before and after exposure to growth factor deprived/FBS-containing diﬀerentiation conditions (UM-FBS). (a) Nontransduced cNPCp20
cultured in UM (proliferation conditions) exhibit baseline cytoplasmic labeling for GDNF (red). (b) Lenti-GDNF-GFP vector transduced
cNPCs cultured in UM show increased intensity of GDNF (red) labeling. (c) Transduced cNPCs cultured in UM-FBS (diﬀerentiation
conditions) are larger in size and show persistent overexpression of GDNF (red), that is, heterogeneously distributed among the proﬁles.
Nuclear labeling = DAPI (blue), scale bar = 50μm.
UM-FBS cultured cNPCs, whereas the glial marker GFAP
was not detected under proliferation conditions, but was
strongly up-regulated by a subset of cells cultured in UM-
FBS. Having conﬁrmed the diﬀerentiating inﬂuence of the
UM-FBSconditions,thesameimmunocytochemicalanalysis
was repeated on cNPCs of identical age that had been
transduced using the lenti-GDNF-GFP vector. The results
were equivalent, suggesting that the diﬀerentiation of cNPCs
was not adversely inﬂuenced by transduction with GDNF
(Figure 8).
4. Discussion
Among mammals, the highly developed visual system of the
domestic cat has been studied in particular detail, owing
in part to greater similarities with the human visual systemJournal of Ophthalmology 9
cNPCp20 control cNPCp20-GDNF-GFP
UM UM UM+FBS UM-FBS
Nestin
Vimentin
Ki-67
GFAP
β3-tubulin
50μm
Figure 8:ExpressionofNPCandlineagemarkersbeforeandaftertransductionanddiﬀerentiation.Theeﬀectsofpassagenumber,induction
ofdiﬀerentiationandGDNFtransgeneexpressionontheexpressionof5markerswasevaluatedusingICC.Nontransducedandlenti-GDNF-
GFPvector transducedcNPCp20 were cultured inUM or UM-FBS,then immunolabeled with speciﬁc antibodies. Thechanges inexpression
patterns seen predominantly reﬂected exposure to diﬀerentiation conditions (alternating columns), with little that might be attributable to
passage number or lenti-GDNF-GFP transduction. Scale bar = 50μm.
as compared to laboratory rodents. This body of work,
combined with the availability of naturally occurring retinal
dystrophic mutants, would serve to recommend the cat as
a powerful model for retinal regeneration research. A major
limiting factor to regenerative research in this species is
the paucity of available donor cells of the type suitable for
such work, including stem, progenitor, or precursor cells
of allogeneic origin. Furthermore, the use of these cells in
transplantation studies would beneﬁt from the inclusion of
a reporter gene and, in some cases, additional transgenes of
potential therapeutic value.
Here we demonstrate the feasibility of using feline
lentiviral vectors to genetically modify cNPCs for sustained
delivery of GDNF. These cells possess multiple desirable
features for use in transplantation studies including ease
of expansion in vitro, coexpression of a green ﬂuorescence
protein (GFP) reporter gene serving to both conﬁrm GDNF
expression as well as allowing easy tracking of donor cells
after transplantation, and sustained transgene expression
following diﬀerentiation. In addition, they are allogeneic
with respect to the targeted host species and therefore likely
to be well tolerated without for the need of exogenous
immune suppression [31].
The ability of a progenitor cell to sustain proliferation
is important in order to avoid the necessity of repeated
rederivation of the modiﬁed cell type. Importantly, the
GDNF-GFP overexpressing cNPCs continued to exhibit log
growth characteristics, indicating that neither the genetic
modiﬁcation process nor GDNF overexpression presents
a major barrier to continued proliferation of these cells.
Nevertheless, the growth of the GDNF-transduced cNPCs
was less rapid than that of unmodiﬁed controls. This slower
growth rate is also reﬂected in the lower number of cells that
were Ki-67 positive following introduction of the transgene
construct. Since we have recently shown that exogenous
GDNF tends to promote, rather than hinder, the growth of
murineRPCs[32],itseemsunlikelythatafeedbacksignaling
mechanism involving the overexpressed cytokine would10 Journal of Ophthalmology
explain the behavior seen here. Perhaps the particularly high
levels of transgene expression maintained by the GDNF-GFP
transduced cNPCs results in a metabolic load that slows
growth relative to unmodiﬁed cells. Alternatively, genetic
modiﬁcation could introduce abnormalities to the host
genome, for instance as a function of the sites of transgene
integration.
Another consideration in terms of clinical application of
transduced cells is the regulation of transgene expression.
Sustained overexpression might result in undesired eﬀects
such as decreased sensitivity to the gene product, as might
result from down-regulation of the corresponding growth
factor receptor or, alternatively, toxic responses to high
levels of the cytokine, either within the eye or systemically.
Titrating the dose of transplanted cells should set an upper
limit on GDNF delivery, since the progenitor cells tend to
cease proliferation in vivo, however, a more sophisticated
approach would be the use of inducible promoters which
allow for the dynamic regulation of transgene expression
levels.
Looking forward, the GDNF-GFP overexpressing cNPCs
developed here are suitable for allogeneic transplantation to
the vitreous cavity or subretinal space of cats with retinal
disease. Of particular interest is the application of these cells
to existing animals with photoreceptor dystrophy, such as
the Swedish Abyssinian breed with the CEP290 mutation
[29], with the goal of ameliorating visual loss through the
sustained intraocular delivery of a neurotrophic factor. In
vivo experiments in this nonrodent species would more
realistically model the prospective treatment of analogous
human conditions and could yield valuable information
pertaining to the mechanisms of graft-mediated eﬀects on
host visual function.
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